02160.HK
MicroPort CardioFlow Medtech Corporation
HKSE · Healthcare · Medical - Devices · CN
HKD 1.28
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 489.8M | 443.8M | 49.5M | 47.5M | 36.7M |
| Cost of Revenue | 214.8M | 155.5M | 15.1M | 15.0M | 12.9M |
| Gross Profit | 275.1M | 288.3M | 34.4M | 32.5M | 23.7M |
| Operating Expenses | |||||
| R&D Expense | 87.6M | 112.5M | 21.0M | 33.5M | 32.7M |
| SG&A Expense | 324.1M | 295.3M | 30.5M | 41.4M | 34.0M |
| General & Admin Expense | 97.3M | 90.1M | 7.9M | 9.9M | 10.5M |
| Selling & Marketing Expense | 226.4M | 205.2M | 22.6M | 31.5M | 23.5M |
| Other Expenses | (8.3M) | (18.4M) | (8.5M) | 1.8M | 11.4M |
| Total Operating Expenses | 403.4M | 389.4M | 43.0M | 76.7M | 78.1M |
| Cost and Expenses | 618.2M | 544.9M | 58.1M | 91.8M | 91.0M |
| Operating Income (EBIT) | (128.3M) | (101.1M) | (8.6M) | (44.3M) | (55.0M) |
| Non-Operating | |||||
| Interest Income | 64.7M | 7.9M | 10.4M | 12.2M | 5.6M |
| Interest Expense | 12.5M | 1.7M | 517.0K | 552.8K | 757.7K |
| Net Interest Income | 52.2M | 6.2M | 9.8M | 11.6M | 4.9M |
| Other Non-Op Income/Expense | (18.6M) | (39.2M) | 2.2M | (21.2M) | (10.9M) |
| Non-Operating Income (excl Interest) | 9.8M | 52.1M | 10.3M | 20.6M | (1.6M) |
| EBT (Pre-Tax Income) | (146.9M) | (140.3M) | (6.3M) | (65.5M) | (65.9M) |
| Income Tax Expense | 7.1M | 6.1M | 959.4K | 1.1M | 452.2K |
| Bottom Line | |||||
| Net Income | (153.4M) | (146.4M) | (6.8M) | (66.6M) | (66.4M) |
| Earnings from Cont. Ops | (153.9M) | (146.4M) | (7.3M) | (66.6M) | (66.4M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (153.4M) | (146.4M) | (6.8M) | (66.6M) | (66.4M) |
| Per Share | |||||
| Basic EPS | (HK$1.51) | (HK$0.30) | (HK$0.01) | (HK$0.14) | (HK$0.14) |
| Diluted EPS | (HK$1.51) | (HK$0.30) | (HK$0.01) | (HK$0.14) | (HK$0.14) |
| Revenue Per Share | HK$4.98 | HK$0.90 | HK$0.11 | HK$0.10 | HK$0.08 |
| Shares | |||||
| Basic Shares Outstanding | 98.4M | 492.1M | 467.8M | 472.6M | 473.1M |
| Diluted Shares Outstanding | 98.4M | 492.1M | 467.8M | 472.6M | 473.1M |
| Profitability Metrics | |||||
| EBITDA | (16.6M) | (111.6M) | (15.5M) | (54.5M) | (50.8M) |
| D&A | 121.5M | 41.6M | 3.4M | 10.4M | 2.6M |
| EBIT | (138.1M) | (153.2M) | (18.9M) | (64.9M) | (53.4M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025